| Primary |
| Contraception |
69.2% |
| Drug Use For Unknown Indication |
18.3% |
| Menorrhagia |
5.8% |
| Product Used For Unknown Indication |
3.2% |
| Endometriosis |
0.4% |
| Depression |
0.4% |
| Vaginal Haemorrhage |
0.4% |
| Hypertension |
0.3% |
| Dysmenorrhoea |
0.2% |
| Anxiety |
0.2% |
| Hypothyroidism |
0.2% |
| Menstruation Irregular |
0.2% |
| Menstrual Cycle Management |
0.2% |
| Pain |
0.2% |
| Asthma |
0.2% |
| Migraine |
0.1% |
| Menstrual Disorder |
0.1% |
| Intra-uterine Contraceptive Device |
0.1% |
| Metrorrhagia |
0.1% |
| Genital Haemorrhage |
0.1% |
|
| Device Expulsion |
30.3% |
| Intra-uterine Contraceptive Device Expelled |
11.0% |
| Vaginal Haemorrhage |
8.8% |
| Pregnancy With Contraceptive Device |
7.3% |
| Device Dislocation |
7.3% |
| Uterine Perforation |
4.2% |
| Uterine Rupture |
3.9% |
| Procedural Pain |
3.6% |
| Iucd Complication |
3.0% |
| Weight Increased |
2.6% |
| Genital Haemorrhage |
2.6% |
| Pain |
2.5% |
| No Adverse Event |
1.9% |
| Amenorrhoea |
1.8% |
| Menorrhagia |
1.7% |
| Post Procedural Haemorrhage |
1.7% |
| Abdominal Pain |
1.6% |
| Iud Migration |
1.5% |
| Pelvic Pain |
1.4% |
| Medical Device Complication |
1.4% |
|
| Secondary |
| Contraception |
57.2% |
| Menorrhagia |
24.5% |
| Drug Use For Unknown Indication |
7.1% |
| Product Used For Unknown Indication |
2.3% |
| Dysmenorrhoea |
1.5% |
| Endometriosis |
1.5% |
| Menstrual Cycle Management |
0.8% |
| Vaginal Haemorrhage |
0.6% |
| Epilepsy |
0.5% |
| Menstrual Disorder |
0.5% |
| Genital Haemorrhage |
0.5% |
| Depression |
0.4% |
| Uterine Leiomyoma |
0.4% |
| Menstruation Irregular |
0.4% |
| Menometrorrhagia |
0.3% |
| Metrorrhagia |
0.3% |
| Pain |
0.3% |
| Migraine |
0.3% |
| Premenstrual Syndrome |
0.3% |
| Ovarian Cyst |
0.2% |
|
| Device Expulsion |
38.9% |
| Device Dislocation |
9.4% |
| Vaginal Haemorrhage |
8.3% |
| Intra-uterine Contraceptive Device Expelled |
8.2% |
| Procedural Pain |
4.7% |
| Genital Haemorrhage |
3.4% |
| Uterine Perforation |
3.4% |
| Menorrhagia |
2.9% |
| Iucd Complication |
2.8% |
| Pain |
2.6% |
| Pregnancy With Contraceptive Device |
2.0% |
| Abdominal Pain |
1.8% |
| Pelvic Pain |
1.6% |
| Uterine Rupture |
1.6% |
| Device Difficult To Use |
1.5% |
| Weight Increased |
1.5% |
| Medical Device Complication |
1.4% |
| Post Procedural Haemorrhage |
1.4% |
| Amenorrhoea |
1.3% |
| No Adverse Event |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.7% |
| Contraception |
20.9% |
| Pain |
6.1% |
| Nuclear Magnetic Resonance Imaging |
4.9% |
| Multiple Sclerosis |
4.7% |
| Acne |
4.0% |
| Depression |
3.8% |
| Crohn's Disease |
3.5% |
| Anxiety |
3.3% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Supplementation Therapy |
2.8% |
| Drug Use For Unknown Indication |
2.7% |
| Premenstrual Syndrome |
2.7% |
| Asthma |
2.4% |
| Migraine |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Psoriasis |
2.2% |
| Prophylaxis |
2.0% |
| Smoking Cessation Therapy |
1.9% |
| Ankylosing Spondylitis |
1.6% |
|
| Pulmonary Embolism |
11.6% |
| Basal Cell Carcinoma |
8.5% |
| Pain |
8.5% |
| Nausea |
7.0% |
| Vomiting |
7.0% |
| Dyspnoea |
4.7% |
| Emotional Distress |
4.7% |
| Injury |
4.7% |
| Rash |
4.7% |
| Stasis Dermatitis |
4.7% |
| Cholelithiasis |
3.9% |
| Menorrhagia |
3.9% |
| Vision Blurred |
3.9% |
| Weight Fluctuation |
3.9% |
| Gallbladder Disorder |
3.1% |
| Headache |
3.1% |
| Heart Rate Irregular |
3.1% |
| Menstrual Disorder |
3.1% |
| Oropharyngeal Pain |
3.1% |
| Syncope |
3.1% |
|
| Interacting |
| Epilepsy |
44.4% |
| Contraception |
22.2% |
| Hyperprolactinaemia |
22.2% |
| Eczema |
11.1% |
|
| Drug Interaction |
66.7% |
| Dizziness |
33.3% |
|
